<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-25-05496-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-25-05496-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Examples of alkaloids active against coronaviruses.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Alkaloid</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coronavirus</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Finding</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Homoharringtonine (HHT)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">EC
     <sub>50</sub> 2.10 μM (reduction in viral copy number)
     <break/>EC
     <sub>50</sub> 2.55 μM (reduction in infectious virus)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B3-molecules-25-05496" ref-type="bibr">3</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">MHV, BCoV-L9 and
     <break/>HECoV-4408
    </td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Inhibits viral replication
     <break/>IC
     <sub>50</sub> 11 nM
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B38-molecules-25-05496" ref-type="bibr">38</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEDV</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC
     <sub>50</sub> 0.112 μM in Vero E6 cells
     <break/>Decreases viral RNA levels in vivo in piglets
     <break/>Specific blockage of viral replication
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B37-molecules-25-05496" ref-type="bibr">37</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Lycorine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">SARS-CoV</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">IC
     <sub>50</sub> 15.7 nM
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B30-molecules-25-05496" ref-type="bibr">30</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-CoV activity likely due to the lycorine modulating host factors instead of directly targeting viral factors</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B50-molecules-25-05496" ref-type="bibr">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxysophoridine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EC
     <sub>50</sub> 0.18 μM and CC
     <sub>50</sub> &gt; 40 μM
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B50-molecules-25-05496" ref-type="bibr">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetrandrine, Fangchinoline, and Cepharanthine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MERS-CoV
     <break/>HCoV-OC43
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Block MERS-pseudovirus translocation through the endolysosomal system
     <break/>Inhibited HCoV-OC43-induced cell death in the early stage of infection and reduced virus replication by suppressing the expression of viral S and N proteins.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B64-molecules-25-05496" ref-type="bibr">64</xref>]
     <break/>[
     <xref rid="B31-molecules-25-05496" ref-type="bibr">31</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tylophorine and Tylophorine analogs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SARS-CoV, MHV, and TGEV
     <break/>SARS-CoV, MERS-CoV, and TGEV
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-CoV replication activity; blocks virus-induced apoptosis and subsequent cytopathic effect in cells in vitro
     <break/>EC
     <sub>50</sub> values for the natural and synthetic tylophorine compounds 8 to 1468 nM and 5 to 340 nM in ST and Vero 76 cells, respectively
     <break/>Targets viral RNA, thereby inhibiting TGEV replication
     <break/>Acts jointly with JAK family inhibitor for comprehensive anti-CoV
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B71-molecules-25-05496" ref-type="bibr">71</xref>]
     <break/>[
     <xref rid="B72-molecules-25-05496" ref-type="bibr">72</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indigo</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SARS-CoV</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the cleavage activities of the 3CLpro
     <break/>IC
     <sub>50</sub> values for cell-free and cell-based assays of 300 μM and 752 μM, respectively
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B76-molecules-25-05496" ref-type="bibr">76</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tryptanthrin and Indigodole B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCoV-NL63</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces viral yield: tryptanthrin (IC
     <sub>50</sub> 1.52 μM); indigodole B (2.60 μM)
     <break/>Virucidal activity: tryptanthrin (IC
     <sub>50</sub> = 0.06 μM); indigodole B (IC
     <sub>50</sub> = 2.09 μM)
     <break/>Tryptanthrin blocks viral RNA genome synthesis and the activity of the papain-like protease 2
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B82-molecules-25-05496" ref-type="bibr">82</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
